Avalyn
formerly Avalyn PharmaceuticalsIPOAvalyn Pharma Inc | Targeted therapies for rare lung diseases
Public · Boston, United States · Founded 2011 · $372.5M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 11–50
- Founded
- 2011
- Business Model
- B2B
- Website
- avalynpharma.com
- Total Funding
- $372.5M
- Last Round
- $100.0M Series DJul 2025
- Rounds
- 5
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Avalyn is a clinical-stage biopharmaceutical company developing inhaled formulations of approved medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases. By delivering drugs directly to the lungs via inhalation, Avalyn aims to improve efficacy and reduce systemic side effects compared to existing oral treatments. The company is led by CEO Lyn Baranowski and CSO Mark Surber, PhD.
Summary
Avalyn is a Biotech company based in Boston, United States, founded in 2011. It has raised $372.5M in total across 5 rounds, most recently a $100.0M Series D round in Jul 2025. Investors include SR One, Novo Holdings A/S and Norwest Venture Partners.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Apr 2026
Sign up to see all 6 events
Funding: Seed through Series D. Amounts, valuations, and investors where available.
Investors
SR One
2 rounds
Novo Holdings A/S
2 rounds
Norwest Venture Partners
2 rounds
Suvretta Capital Management
1 round
Eventide Asset Management
1 round
Perceptive Advisors
1 round
Eight Roads Ventures
1 round
Catalio Capital Management
1 round
F-Prime Capital
1 round
Pivotal bioVenture Partners
1 round
RiverVest Venture
1 round
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/avalyn"><img src="https://indexed.vc/api/badge/company/avalyn" alt="Avalyn on Indexed.vc" width="260" height="76" /></a>